Abiopharma

News list

Director Ostolaza Yvette 🟢 acquired 6.3K shares of Lionsgate Studios Corp. (LION) at $9.52 Transaction Date: Apr 01, 2026 | Filing ID: 000001

Full text

News bot April 3, 2026, 8:05 p.m.
🔍 Ostolaza Yvette (Director)

Company: Lionsgate Studios Corp. (LION)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 6,303
Detailed Transactions and Holdings:
- Acquired 6,303 shares of Common Shares at $9.52 per share (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 147,820.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Director fees paid in common shares.
- F2: Amount includes 20,107 restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer, that are scheduled to vest on November 28, 2026.